Dementia News and Research

Latest Dementia News and Research

Remembering proper eating habits can improve physical health and reduce depression

A new analysis has found that a combination of methods that help patients with dementia remember proper eating habits can improve their physical health and lessen symptoms of depression.

1 Mar 2013

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced the U.S. Food and Drug Administration (FDA) has approved ABILIFY MAINTENA (aripiprazole) for extended- release injectable suspension, an intramuscular (IM) depot formulation indicated for the treatment of schizophrenia.

1 Mar 2013

Jones & Bartlett Learning publishes 'Introduction to Neurogenic Communication Disorders'

M. Hunter Manasco, Ph.D., C.C.C.-S.L.P., assistant professor of speech-language pathology at Misericordia University, has had the textbook and video combination, "Introduction to Neurogenic Communication Disorders,'' published by Jones & Bartlett Learning.

28 Feb 2013

Proper eating habits in dementia patients can improve their physical health and lessen symptoms of depression

A new analysis has found that a combination of methods that help patients with dementia remember proper eating habits can improve their physical health and lessen symptoms of depression. Published early online in the Journal of Advanced Nursing, the study indicates that clinicians should consider using this intervention in individuals with dementia who also have poor nutrition and signs of depression.

28 Feb 2013

MID1 complex binds with messenger RNA and controls synthesis of defective Huntingtin

Huntington's disease, also known as Huntington's chorea, is a hereditary brain disease causing movement disorders and dementia. In Germany, there are about 8,000 patients affected by Huntington's disease, with several hundred new cases arising every year. The disease usually manifests between the ages of 35 and 50.

27 Feb 2013

Major doctor group coalition expands list of tests, treatments that should be done only rarely

The American Board of Internal Medicine, as part of its "Choosing Wisely" campaign, expanded the number of medical societies recommending caution before certain tests and procedures are ordered.

22 Feb 2013

Dietary antioxidants may not protect against stroke and dementia

Contrary to other research, a new study found that the total level of antioxidants in people's diets is not related to their risk of developing stroke or dementia.

21 Feb 2013

Methylene blue inactivates molecular residues that promote bonding of tau proteins

The study published in "Angewandte Chemie" might help to work out strategies for developing potential drugs. As the team of scientist including Markus Zweckstetter and Eckhard Mandelkow report, methylene blue inactivates molecular residues that promote the bonding of tau proteins.

21 Feb 2013

New system can help spot sleep disturbance in people with early dementia

A new sleep pattern monitoring system has been developed by UK researchers to help spot sleep disturbance in people diagnosed with early dementia. The system, known as PAViS, could be used remotely by healthcare workers to view sleep profiles and analyse sleep patterns based on sensory data gathered at the patient's home.

19 Feb 2013

Brain health just as important as physical health

We all know the importance of keeping healthy and are familiar with the refrains of 'exercise more', 'eat better' and 'get regular physicals'. But what about our mental health? Professor Barbara Sahakian, best known for her expertise on cognitive enhancers, challenges society (and government) to prioritise mental health in the same way as we do physical health.

17 Feb 2013

The Y rolls out new health program targeting diabetes

YMCAs will advance the program nationally with support from insurers and employers. Also in the news, researchers express concern about the increasing costs likely to accompany soaring Alzheimer's disease rates.

16 Feb 2013

TSG might be novel compound for treatment of Alzheimer's and dementia with Lewy body

Administration of the active compound tetrahydroxystilbene glucoside (TSG) derived from the Chinese herbal medicine Polygonum multiflorum Thunb, reversed both overexpression of α-synuclein, a small protein found in the brain, and its accumulation using a mouse model of Alzheimer's disease.

16 Feb 2013

Tau release from healthy neurons can be regulated by neuronal activity

Researchers from King's College London have discovered that neuronal activity can stimulate tau release from healthy neurons in the absence of cell death.

16 Feb 2013

First Edition: February 15, 2013

Today's headlines include news about how the health law's insurance exchanges are taking shape.

15 Feb 2013

Study finds abnormal production of C9RANT in patients with ALS, frontotemporal dementia

Researchers at Mayo Clinic have discovered an abnormal protein that accumulates in the brains of many patients affected with two common neurodegenerative disorders — amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease, and frontotemporal dementia.

13 Feb 2013

Boston College biologist receives $2.7M NIH grant to continue HIV and AIDS research

Boston College biologist Ken Williams, whose research focuses on the role of immunological cells in a range of illnesses that strike people living with HIV and AIDS, has been awarded a five-year, $2.7 million grant from the NIH's National Institute of Neurological Disorders and Stroke.

12 Feb 2013

Brookdale fourth quarter total revenue increases 4.1% to $699.7 million

Brookdale Senior Living Inc. today reported financial and operating results for the fourth quarter and full year 2012.

11 Feb 2013

Scientists identify enigmatic aggregates linked to neurodegenerative diseases

The proteins that have now been identified shouldn't actually exist. Nevertheless, they build the core of cellular aggregates whose identity has been enigmatic until now. These aggregates are typically associated with hereditary neurodegenerative diseases including variants of frontotemporal dementia (FTD), also known as frontotemporal lobar degeneration (FTLD), and amyotrophic lateral sclerosis (ALS). They are likely to be damaging and might be a target for therapy.

11 Feb 2013

FDA issues draft guidance on developing new treatments for Alzheimer's

Today, the U.S. Food and Drug Administration issued a proposal designed to assist companies developing new treatments for patients in the early stages of Alzheimer's disease, before the onset of noticeable (overt) dementia.

11 Feb 2013

Academic medical centers play an integral role in developing new treatments and cures

As an internationally recognized researcher into aging and dementia, Suzanne Craft is keenly aware of the importance of volunteers in clinical studies.

9 Feb 2013

Dementia News and Research

Latest Dementia News and Research

Remembering proper eating habits can improve physical health and reduce depression

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Jones & Bartlett Learning publishes 'Introduction to Neurogenic Communication Disorders'

Proper eating habits in dementia patients can improve their physical health and lessen symptoms of depression

MID1 complex binds with messenger RNA and controls synthesis of defective Huntingtin

Major doctor group coalition expands list of tests, treatments that should be done only rarely

Dietary antioxidants may not protect against stroke and dementia

Methylene blue inactivates molecular residues that promote bonding of tau proteins

New system can help spot sleep disturbance in people with early dementia

Brain health just as important as physical health

The Y rolls out new health program targeting diabetes

TSG might be novel compound for treatment of Alzheimer's and dementia with Lewy body

Tau release from healthy neurons can be regulated by neuronal activity

First Edition: February 15, 2013

Study finds abnormal production of C9RANT in patients with ALS, frontotemporal dementia

Boston College biologist receives $2.7M NIH grant to continue HIV and AIDS research

Brookdale fourth quarter total revenue increases 4.1% to $699.7 million

Scientists identify enigmatic aggregates linked to neurodegenerative diseases

FDA issues draft guidance on developing new treatments for Alzheimer's

Academic medical centers play an integral role in developing new treatments and cures

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Dementia News and Research

Latest Dementia News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in